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Abstract In this study, we present identification and
physicochemical characterization of new cathinone
derivatives, 4-fluoro-PV9 and already known a-PHP in
seized materials. Although the disclosure of a-PHP from an
illegal product had been reported and characterized to some
extent, the data on a-PHP are also presented together with
those of 4-fluoro-PV9. The data of characterization for the
two compounds were obtained by high-performance liquid
chromatography (HPLC)–mass spectrometry and HPLC–
diode array detection, electrospray ionization/ion trap mass
spectrometry in MS2 and MS3 modes, gas chromatogra-
phy–mass spectrometry, thermogravimetric analysis, dif-
ferential scanning calorimetry, Fourier transform infrared
spectroscopy, ultraviolet-visible spectroscopy, and nuclear
magnetic resonance spectroscopy. To our knowledge, this
is the first report for identification and detailed character-
ization of 4-fluoro-PV9 circulated on the illegal drug
market.
Keywords Designer drugs  4-Fluoro-PV9  a-PHP 
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Introduction
In the global market of designer drugs, new products
continuously appear that contain already known psy-
choactive compounds and mixtures thereof, but also new
compounds, not yet characterized in any way [1–3].
According to the European Early Warning System, in
Europe in 2005 alone, 14 novel psychoactive compounds
were identified, and in 2013 the number of such com-
pounds grew to over 80 items [1, 4]. Striking features are a
wide spectrum of the marketed compounds and the forms
in which they are traded. In Poland, consumables con-
taining psychoactive ingredients are currently marketed as
‘‘fireplace kindling’’, ‘‘bidet refreshers’’, ‘‘humidity adsor-
bents’’, ‘‘driver’s charms’’, or ‘‘leech tamers’’. Among the
substances seized on the Polish and European Union drug
market, derivatives of piperazine and phenylethylamine are
frequently found, along with the synthetic cannabinoids,
but the most frequently identified group is that of the
cathinone derivatives [1–3, 5–11].
Synthetic analogs of cathinone can be divided into four
groups; i.e., those containing N-alkyl- or alkyl/halogen
substituents in any given position of the aromatic ring,
those with methylenedioxy-substituted structures also in
any given position of the aromatic ring, those with a
pyrrolidinyl group at the nitrogen atom, and those with
combined substituents of the second and the third groups
[12–16]. Among the most frequently identified cathinones
distributed on the Polish market, one can find 3-MMC
(2-(methylamino)-1-(3-methylphenyl)-1-propanone), pent-
edrone (2-(methylamino)-1-phenyl-1-pentanone), 4-MEC
(2-(ethylamino)-1-(4-methylphenyl)-1-propanone), MDPV
(3,4-methylenodioxypyrovalerone), a-PVP (1-phenyl-2-(1-
pyrrolidinyl)-1-pentanone), and MDPBP (3,4-methylen-
odioxy-a-pyrrolidinobutiophenone) [17–21].
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Due to an increasing number of designer drugs available
on the drug market and taking into account the vital pos-
sibility of synthesizing and manufacturing structural mod-
ifications of already known psychoactive substances, the
availability of analytical characteristics of these com-
pounds is inevitable for their efficient and rapid identifi-
cation [8, 18, 22–26]. In this study, we present, for the first
time to our knowledge, analytical characteristics of 4-flu-
oro-PV9 (1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)octan-1-
one) in seized materials. Although we could detect a-PHP
(1-phenyl-2-(1-pyrrolidinyl)-1-hexanone) from another
seized material, its disclosure from an illegal product had
been reported by Uchiyama et al. [27].
We mainly present and discuss relevant analytical data
obtained for 4-fluoro-PV9 and a-PHP by high-performance
liquid chromatography–mass spectrometry (HPLC–MS)
and high-performance liquid chromatography–diode array
detection (HPLC–DAD), ion trap mass spectrometry with
electrospray ionization (ESI) in the MS2 and MS3 modes,
gas chromatography–mass spectrometry (GC–MS), ther-
mogravimetric analysis (TGA), differential scanning
calorimetry (DSC), Fourier transform infrared (FTIR)
spectroscopy, ultraviolet-visible (UV-VIS) spectroscopy
and proton and carbon nuclear magnetic resonance spec-
troscopy (1H NMR and 13C NMR).
Materials and methods
Chemicals
In our study, all reagents used were of the HPLC and MS
purity grade. Water (Chromasolv), methanol, acetonitrile,
0.1 M formic acid and ammonium formate were purchased
from Sigma-Aldrich, Poznan´, Poland. For the NMR anal-
ysis, deuterated chloroform (CDCl3), also purchased from
Sigma-Aldrich, was used.
Sample preparation
The analyzed samples were seized by the police in 2014 in
the Silesia region of South Poland and delivered to our lab-
oratory for toxicological examination. Both samples were
obtained in powdered form. Sample no. 1 was crumbled pale
pink powder, and sample no. 2 was lumped beige powder.
For the purpose of liquid and gas chromatography, 10-mg
aliquots of each powder were weighted, dissolved in 1 mL of
acetonitrile/methanol (50:50, v/v) mixture, and ultrasonicated
for 10 min. From each solution, 10 lL were collected and
diluted with 990 lL methanol. Finally, the extracts were
ready for analysis. For NMR spectroscopic analysis, 10 mg of
each sample was dissolved in 0.6 mL CDCl3 and analyzed.
For the purpose of FTIR, a 2-mg aliquot of each sample was
taken and mixed with KBr, and pellets were formed. The KBr
pellets were analyzed. For the purpose of TGA, DSC and UV-
VIS spectroscopy, a 5-mg aliquot of each sample was taken
for analysis. The TGA and DSC analysis were performed
without any further sample treatment, and for the UV-VIS
analysis, the samples were dissolved in methanol.
HPLC–MS and HPLC–DAD conditions
In our investigations, the high-performance liquid chro-
matograph Thermo Surveyor coupled with the mass spec-
trometer Thermo LCQ DecaXP-Plus with an electrospray
ionization source (Thermo Scientific, Warsaw, Poland) was
used. The obtained data were processed with use of the
Xcalibur and LCQTune programs (Thermo Scientific).
For the HPLC–MS analysis, the Hypersil RP C18 col-
umn (150 9 4.6 mm) (Thermo Scientific) was used and
analysis was carried out in gradient mode. Mobile phase
was composed of solvent A (0.02 M water solution of
formic acid/0.05 M water solution of ammonium formate)
and solvent B (10 % solvent A/90 % acetonitrile), and the
following gradient program was applied: 0–2 min, 95 %
(A) ? 5 % (B); 2–30 min, 30 % (A) ? 70 % (B);
30–32 min, 30 % (A) ? 70 % (B); 32–40 min, the solvent
ratio was returned to the initial state, i.e., 95 % (A) ? 5 %
(B). The mobile phase flow rate was 100 lL min-1.
The analytes were electrosprayed in the positive mode
(ESI(?)-MS). Fragmentation in the ESI-MS2 and ESI-MS3
mode was carried out in the scanning range of m/z 50–500.
The source temperature was 250 C, and the carrier and
ionizing gases were nitrogen and helium, respectively.
GC–MS analysis
For GC–MS analysis, the Thermo Trace Ultra chro-
matograph was used, coupled with the Thermo DSQ mass
spectrometer (Thermo Scientific). The analyses were car-
ried out with use of the Rxi-5Sil MS column (Restek,
Bellefonte, PA, USA). The following working parameters
were employed: injector temperature, 260 C; oven tem-
peratures, 100 C for 2 min, ramp at 20 C min-1 to
260 C; carrier gas (helium) flow rate, 1.2 mL min-1; MS
transfer line temperature, 250 C; MS source temperature,
250 C; injection volume, 1 lL, on splitless mode.
The obtained electron ionization (EI) mass spectra were
compared to those of an EI-MS library [28] for structural
confirmation.
NMR spectroscopy
The NMR spectra were recorded with use of the Ultra-
Shield 400 MHz apparatus (Bruker, Bremen, Germany).
Deutered chloroform was used as solvent.
116 Forensic Toxicol (2016) 34:115–124
123
Fig. 1 a Total ion current chromatogram (TIC) and b the single-stage mass spectrum of the intense peak appearing in the TIC obtained from the
compound in sample no. 1, recorded by high-performance liquid chromatography–mass spectrometry (HPLC–MS)
Fig. 2 Product ion mass spectra obtained by ion trap mass spectrometry (MS) in the a MS2 (tandem) and b MS3 modes for sample no. 1. The
precursor ions used for the MS2 and MS3 modes were those at m/z 292 and 274, respectively
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Thermogravimetric analysis (TGA) and differential
scanning calorimetry (DSC)
TGA was carried out with use of the TGA/DSC1 Mettler–
Toledo thermal analyzer (Mettler–Toledo, Greifensee,
Switzerland), with a heating rate of 10 C/min in a stream
of nitrogen (60 cm3 min-1). DSC was performed with a
TA-DSC 2010 apparatus (TA Instruments, New Castle,
DE, USA) under nitrogen using aluminum sample pans.
The DSC experiments were carried out in a nitrogen
atmosphere with a temperature range from -70 C to over
the clearing point.
Fourier transform infrared and UV-VIS
spectroscopy
The infrared (IR) spectra were acquired with use of the
PerkinElmer Spectrum One spectrometer (PerkinElmer,
Waltham, MA, USA) using the KBr pellets. The UV-VIS
absorption spectra were recorded in the methanol solution
using the PerkinElmer Lambda Bio 40 UV-VIS
spectrometer.
Results and discussion
Identification of the compound contained in sample
no. 1
Upon analysis of sample no. 1 by HPLC–MS, the total ion
current (TIC) chromatogram (Fig. 1a) showed an intense
peak at 25.27 min. Otherwise, no marked peaks appeared,
showing that sample no. 1 contained almost a single
compound with high purity (probably more than 95 %).
Figure 1b shows the HPLC–MS spectrum of the intense
peak observed in Fig. 1a; a base peak appeared at m/z 292.
Because this peak seemed to be protonated molecular one
Fig. 3 Mass spectrum of the
compound contained in sample
no. 1, obtained by gas
chromatography–mass
spectrometry (GC–MS) in the
electron ionization (EI) mode
Table 1 1H and 13C nuclear magnetic resonance (NMR) data for
sample no. 1
Carbon atom
position
Carbon chemical
shifts (ppm)
Proton chemical
shifts (ppm)
1 195.20 –
2 64.87 5.50 (dt, 1H)
3 31.13 2.08 (m, 2H)
4, 5, 6, 7 30.82; 29.11;
25.52; 22.36
1.15–1.35 (m, 8H)
8 13.85 0.79 (t, 3H)
9 52.72 3.12 (m, 1H);
3.86 (m, 1H)
10, 11 23.85; 23.66 2.18 (m, 4H)
12 51.23 3.69 (m, 2H)
13, 15 116.51; 116.53 7.22 (m, 2H)
14 165.53; 168.10 –
16, 18 131.88; 131.93; 131.96 8.13 (m, 2H)
17 131.79 –
The carbon atom numbering is shown in Fig. 4a
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[M ? H?], the unknown compound may have a molecular
weight of 291 Da. In the product ion mass spectra in the
MS2 (tandem) mode using the peak at m/z 292 as the
precursor ion, a peak at m/z 274 appeared (Fig. 2a), which
indicated the elimination of one water molecule from the
protonated molecular ion [M ? H – H2O]
?. This trans-
formation is a well-known characteristic of cathinone
derivatives. Given that this compound is assumed to be one
of the cathinone derivatives, the product ion mass spectrum
in the MS3 mode using the peak at m/z 274 as the precursor
ion, which neither includes a carbonyl nor hydroxyl group,
showed a base peak at m/z 203 and a fragment peak at m/z
189 (Fig. 2b), suggesting that the cathinone derivative has
pyrrolidinyl and fluorophenyl moieties in its structure. The
appearance of the base peak at m/z 221 in Fig. 2a is easily
explicable by removal of the pyrrolidinyl moiety from the
molecule.
Unfortunately, in this study, we did not use the high-
resolution MS that can give a molecular formula. Instead,
we compared the GC–EI-MS spectra to those of an EI-MS
spectral library, and fortunately, the EI-MS spectrum
obtained from sample no. 1 matched well with that of
4-fluoro-PV9, which had very recently been added to the
library. In both spectra, the peak at m/z 168 appeared as the
base peak; the fragment peaks at m/z 169, 123, 110, 95, 84
and 55 appeared to be in common (Fig. 3).
Therefore, it seemed correct that the compound con-
tained in sample no. 1 was fluoro-PV9, but the question of
which position of the phenyl ring the fluorine atom was
attached remained unclear, because it is well known that
such regioisomers give the same or very similar EI-mass
spectra.
To finally determine the position of the fluorine atom in
the aromatic ring, the NMR spectrum was recorded, as
shown in Table 1. The carbon numbering is shown in
Fig. 4a.
As a result, confirmation of the anticipated structure
was obtained. Namely, in the aromatic range of the 1H
NMR spectrum, two signal groups appeared, and wit-
nessed to the presence of the fluorine atom at position
para of the phenyl ring. Due to the proton interactions
with the fluorine atom, two multiplets were observed
instead of a ‘‘classical’’ signal arrangement (i.e., the
doublets for each group of equivalent protons). Coupling
with the fluorine atom was also visible in the 13C NMR
spectrum, where signals originating from carbon atom no.
14, and those from no. 13 and 15 are split to the doublets.
Fig. 4 Target compound structures with carbon atom numbering for
nuclear magnetic resonance analysis. a The compound contained in
the sample no. 1; b the compound contained in sample no. 2
Fig. 5 a TIC and b the single-stage mass spectrum of the intense peak appearing in the TIC, obtained from the compound in sample no. 2
recorded by HPLC–MS
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Due to the fact that sample no. 1 appeared as a
hydrochloride, in the 1H NMR spectrum, a signal is
observed at 11.95 ppm, originating from the proton of the
quaternary pyrrolidine group. Therefore, it can be
concluded that the compound contained in sample no. 1 is
4-fluoro-PV9 (1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)octan-
1-one). To our knowledge, this is the first report to
identify 4-fluoro-PV9 in an authentic seizure sample.
Fig. 6 Product ion mass spectra obtained by ion trap MS in a MS2 (tandem) and b MS3 modes for sample no. 2. The precursor ions used for the
MS2 and MS3 modes were those at m/z 246 and 175, respectively
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Identification of the compound contained in sample
no. 2
Upon analysis of sample no. 2 by HPLC–MS, the TIC
(Fig. 5a) showed an intense peak at 18.58 min. Otherwise,
no marked peaks appeared, showing that sample no. 2
contained almost a single compound with high purity.
Figure 5b shows the HPLC–MS spectrum of the intense
peak observed in Fig. 5a; a base peak appeared at m/z 246.
In the product ion mass spectrum in the MS2 mode
(Fig. 6a), the peak due to elimination of one water mole-
cule at m/z 228 also appeared, suggesting that the com-
pound is also a cathinone derivative, and the peak due to
the elimination of the pyrrolidinyl moiety appeared as the
base peak at m/z 175. The product ion mass spectrum in the
MS3 mode was also recorded using the ion at m/z 175 as
the precursor ion for further analysis of the probable
structure (Fig. 6b).
Figure 7 shows the GC–MS spectrum of the compound
in sample no. 2, and it was compared to that described in
the library [28]. The EI-mass spectrum obtained from
sample no. 2 was well matched that of a-PHP (1-phenyl-2-
(1-pyrrolidinyl)-1-hexanone). In both spectra, the peak at
m/z 140 appeared as the base peak; the fragment peaks at
m/z 141, 105, 96 and 77 appeared in common.
As shown in Table 2, the data from 1H NMR and 13C
NMR analysis of sample no. 2 confirmed the presence of a-
PHP (the carbon numbering is shown in Fig. 4b). Similar to
sample no. 1, the compound in sample no. 2 was also
present in the hydrochloride form, which resulted in the
appearance of a signal at 12.65 ppm originating from the
proton of the quaternary pyrrolidine group.
It should be mentioned that Uchiyama et al. [27]
reported the identification of a-PHP in an illegal product in
2014; they reported GC–MS mass spectrum, UV spectrum
and 1H NMR and 13C NMR for a-PHP, which generally
agree with the data described in this study.
Fig. 7 Mass spectrum of the
compound contained in sample
no. 2, obtained by GC–MS in
the EI mode
Table 2 1H and 13C NMR data for sample no. 2
Carbon atom
position
Carbon chemical
shifts (ppm)
Proton chemical
shifts (ppm)
1 196.78 –
2 62.87 5.15 (dt, 1H)
3 30.62 2.03 (m, 2H)
4, 5 27.93; 22.50 1.33 (m, 4H)
6 13.48 0.84 (t, 3H)
7 52.90 2.83 (m, 1H); 3.68 (m, 1H)
8, 9 23.93; 23.71 2.21 (m, 4H)
10 49.51 3.84 (m, 2H)
11, 13 129.43 7.58 (t, 2H)
12 135.16 7.73 (t, 1H)
14,16 128.62 7.98 (d, 2H)
15 135.75 –
The carbon atom numbering is shown in Fig. 4b
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Other physicochemical analytical results for 4-
fluoro-PV9 and a-PHP identified in this study
The UV spectra recorded by HPLC–DAD and UV-VIS
spectrometry showed absorption maxima at 254 and
253 nm, respectively, for the compound in sample no. 1 (4-
fluoro-PV9); they were 252 and 251 nm, respectively, for
that in sample no. 2 (a-PHP) (Fig. 8). The symmetrical
peaks and the absence of impurity peaks in the spectra
show that each compound existed in the materials in high
purity.
The TGA spectra for both compounds are shown in
Fig. 9a, b, respectively. Both spectra showed single main
transitions corresponding to their decomposition. The
decomposition temperatures for those in sample no. 1 and
sample no. 2 were 259 and 250 C, respectively. The only
one main transition observed for each compound shows
that the purity of each compound was high.
By DSC analysis, melting points for the compounds in
the samples no. 1 and no. 2 were 144 and 65 C, respec-
tively; those measured in the classic way were 140–142
and 62–64 C, respectively.
By the FTIR spectroscopy, a strong carbonyl stretch at
1685 cm-1, the aliphatic CH stretching at 2800–3000 cm-1
and the amine hydrochloride salt bands at 2476–2752 cm-1
were observed for the compound in the sample no. 1; a
strong carbonyl stretch at 1678 cm-1, the aliphatic CH
stretching at 2800–3000 cm-1 and the amine hydrochloride
salt bands at 2494–2750 cm-1 were observed for the com-
pound in sample no. 2. Due to the structural similarity of
Fig. 8 Ultraviolet-visible spectroscopy for the compounds contained in a sample no. 1 and b sample no. 2
Fig. 9 Thermogravimetric spectra for the compounds contained in a sample no. 1 and b sample no. 2
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both compounds, their IR spectra were very similar, as
described above.
Conclusions
In this study, we experienced the analysis of compounds in
two seized materials. We used various analytical tools for
their identification and characterization, such as HPLC–
MS, HPLC–DAD, ion trap MS in MS2 and MS3 modes,
GC–MS, TGA, DSC, FTIR spectroscopy, UV-VIS spec-
troscopy and 1H and 13C NMR spectroscopy. The com-
pounds contained in sample no. 1 and no. 2 were found to
be 4-fluoro-PV9 and a-PHP, respectively. Although a-PHP
had been identified and characterized to some extent in
2014, to our knowledge, this is the first report on the
identification and characterization of 4-fluoro-PV9. The
data presented in this article will be useful for forensic
toxicologists who are alert to the emergence of new psy-
chotropic drugs.
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